Kurt Scheinpflug

Title: Kurt Scheinpflug: Innovator in Ingestible Technology

Introduction

Kurt Scheinpflug is a notable inventor based in Fremont, CA, with a focus on innovative technologies in the field of ingestible devices. He holds a total of six patents, showcasing his contributions to advancements in healthcare and digital health solutions.

Latest Patents

Among his latest patents are methods for manufacturing capsules with ingestible event markers. These capsules include a digital, ingestible sensor component that activates upon contact with conductive fluids, such as stomach fluid. Once activated, the sensor can transmit signals and gather biometric data from the individual who ingested the capsule. Another significant patent involves lisinopril compositions with an ingestible event marker, which includes various formulations of lisinopril combined with silicon, magnesium metal, and copper (I) chloride. These innovations highlight Scheinpflug's commitment to enhancing medical technology through ingestible solutions.

Career Highlights

Kurt Scheinpflug has worked with prominent companies in the pharmaceutical and digital health sectors, including Otsuka Pharmaceutical Company, Limited and Proteus Digital Health, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of ingestible technologies.

Collaborations

Throughout his career, Scheinpflug has collaborated with talented individuals such as Nikhil Pargaonkar and Chris Dong. These partnerships have played a crucial role in the development of his patented technologies.

Conclusion

Kurt Scheinpflug's work in the field of ingestible technology demonstrates his innovative spirit and dedication to improving healthcare solutions. His patents reflect significant advancements that have the potential to transform patient care and monitoring.